Kraig Biocraft Laboratories Inc (KBLB)

[jimmy$teel]

Kraig Biocraft Laboratories, Inc. to Employ Artificial DNA Sequences for Development of New Materials for Technical Textile Market and Albemarle chairman gives up role; CEO Rohr to take over
--(www.USEquityNews.com)-- 05/07/2008 - Basic Materials industry alert provided by U.S. Equity News. Kraig Biocraft Laboratories, Inc. (OTC BB: KBLB) announced recently that the Company, working in cooperation with leading university laboratories, is synthesizing DNA sequences for artificial spider silk based polymers. The artificial DNA which the Company is developing relates to the discovery of a chimera molecule, the subject of a 2008 provisional patent filing, which incorporates high strength spider silk proteins. ``Our artificial DNA sequences are designed for use in the development and production of a new class of high performance fibers,'' said Kraig's CEO Kim Thompson. ``We are developing these fibers, spider silk analogs, specifically to capture a share of the growing technical fibers market. This is the primary market for high strength fibers. The market for technical fibers is booming. Within two years it is projected to grow to $127 billion. We believe that these revolutionary materials will have tremendous potential in the technical textiles marketplace for high strength polymers.''